Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-003299-22Phase 4Completed
Phase 4 trial of bilastine (2 arms), sponsored by TNO. Primary endpoints: Vigilance and Tracking Test (VigTrack) root mean square of tracking error, Vigilance and Tracking Test (VigTrack) percentage omissions and 1 more. Started Nov 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-003299-22.